依立替康,irinotecan
1)irinotecan依立替康
1.Combination chemotherapy with irinotecan and cisplatin as second-line treatment for small cell lung cancer;依立替康联合顺铂二线治疗小细胞肺癌
2.A randomized controlled clinical trial on irinotecan/cisplatin versus gemcitabine/cisplatin as the first-line treatment in advanced non-small cell lung cancer;依立替康/顺铂与吉西他滨/顺铂方案一线治疗晚期非小细胞肺癌随机对照临床研究
3.Irinotecan/cisplatin versus Etoposide/cisplatin for Patients with Extensive Stage Small Cell Lung Cancer:A Systematic Review依立替康联合顺铂与足叶乙甙联合顺铂治疗广泛期小细胞肺癌的系统评价
英文短句/例句

1.Establishment of a model of Irinotecan- induced Diarrhea in Nude Mice Bearing Human Small-cell Lung Cancer依立替康致小细胞肺癌荷瘤鼠腹泻模型的建立
2.Clinical Efficacy of Irinotecan for Extensive Small-Cell Lung Cancer依立替康应用于广泛期小细胞肺癌的疗效观察
3.The Study of the Intervention of Banxiaxiexin Decoction against Irinotecan- induced Diarrhea in Nude Mice Bearing Human Small-cell Lung Cancer半夏泻心汤干预依立替康致小细胞肺癌荷瘤鼠腹泻的研究
4.Clinical study on combination chemotherapy with irinotecan,fluorouracil,and leucovorin in patients with advanced gastric carcinoma依立替康/氟尿嘧啶/亚叶酸三药联用治疗晚期胃癌的临床疗效观察
5.Study on the Improvement and Mechanism of Banxiaxiexin Decoction against Irinotecan-induced Diarrhea in Nude Mice Bearing the Tumor of Human Small-cell Lung Cancer半夏泻心汤对依立替康致小细胞肺癌荷瘤鼠腹泻的改善作用及机理研究
6.Irinotecan/cisplatin versus Etoposide/cisplatin for Patients with Extensive Stage Small Cell Lung Cancer:A Systematic Review依立替康联合顺铂与足叶乙甙联合顺铂治疗广泛期小细胞肺癌的系统评价
7.Efficacies of capecitabine combined with irinotecan or rh-endostatin for treatment of oxaliplatin-resistant patients with advanced colorectal cancer卡培他滨联合血管内皮抑素或依立替康治疗奥沙利铂耐药晚期结直肠癌
8.Irinotecan in the Treament of Small Cell Lung Cancer (SCLC): A Systematic Review伊立替康治疗小细胞肺癌的系统评价
9.Effect of Irinotecan Combined with Radiotherapy in Patients with Advanced Non-small Cell Lung Cancer伊立替康联合放疗治疗晚期NSCLC的疗效
10.Clinical comparison between single agent of irinotecan and combination of irinotecan and cispaltin in second-line treatment of small cell lung cancer伊立替康单药与伊立替康联合顺铂二线治疗小细胞肺癌的临床比较
11.Preparation of Irinotecan Hydrochloride Liposome and the in Vitro and in Vivo Pharmaceutical Behaviors of Irinotecan Liposome;伊立替康脂质体的制备及体内外行为研究
12.Determination of Stabilization of Irinotecan in 0.9% Sodium Chloride Injection by HPLC伊立替康浓度测定及其输液稳定性考察
13.Clinical Study of Advanced Ovarial Cancer with Irinotecan and Cisplatin Regimen Combination伊立替康联合顺铂治疗晚期卵巢癌的疗效观察
14.The Efficacy Observation of Irinotecan Therapy of Patients with Recurrent Advanced Ovarian Carcinoma伊立替康治疗复发性晚期卵巢癌的临床观察
15.CLINICAL OBSERVATION ON THE IRINOTECAN PLUS CISPLATIN FOR ADVANCED ESOPHAGEAL CANCER伊立替康联合顺铂治疗晚期食管癌疗效观察
16.Irinotecan combined with capecitabine in line-2 treatment of locally advanced or metastatic gastric cancer伊立替康联合卡培他滨二线治疗晚期胃癌
17.Technetium[99mTc] Etifenin锝[99mTc]依替菲宁
18.Abuse of Dependence-Producing Substances and Rehabilitation Centers Act, No. 41 of 1971滥用产生依赖性物质和设立康复中心法,
相关短句/例句

Irinotecan伊立替康
1.Advancement in the Synthesis and Clinical Application of the New Anticancer Drug Irinotecan;抗肿瘤新药伊立替康的合成和应用进展
2.The adverse reactions and management of irinotecan;盐酸伊立替康的不良反应及其预防处理
3.Short-term effects of irinotecan plus capecitabine as first-line treatment for advanced colorectal carcinoma;伊立替康联合卡培他滨—线治疗晚期结直肠癌的近期疗效
3)Irinotecan hydrochloride盐酸依列替康
4)Irinotecan hydrochloride盐酸伊立替康
1.Preparation and quality evaluation of irinotecan hydrochloride lyophilized liposomes盐酸伊立替康脂质体冻干粉针的制备及其质量评价
2.Preparation of irinotecan hydrochloride containing liposomes by ammonium sulfate gradient method and its release in vitro硫酸铵梯度法制备盐酸伊立替康脂质体及体外释放的研究
3.METHODS:Irinotecan hydrochloride liposome was prepared by ammonium sulfate gradient method.目的:制备盐酸伊立替康脂质体并考察其体外释药特性。
5)Irinotecan(CPT-11)伊立替康(CPT-11)
6)irinotecan/therapeutic use伊立替康/治疗应用
延伸阅读

依立雄胺分子式:暂无分子量:暂无CAS号:119169-78-7性质:暂无制备方法:暂无用途:睾酮还原酶抑制剂。